The retrospective analysis of 343 Czech patients with IgA nephropathy-one centre experience

Nephrology Dialysis Transplantation

Volumn 27, Issue 4, 2012, Pages 1492-1498

  Maixnerova, Dita ^a   Bauerova, Lenka ^a   Skibova, Jelena ^b   Rysava, Romana ^a   Reiterova, Jana ^a   Merta, Miroslav ^a   Honsova, Eva ^a   Tesar, Vladimir ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

hypertension; IgA nephropathy; immunosuppressive treatment; proteinuria; renal insufficiency

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; AZATHIOPRINE; CORTICOSTEROID; CREATININE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADULT; AGED; ARTERY INTIMA PROLIFERATION; ARTICLE; ATROPHY; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CZECH REPUBLIC; DISEASE ASSOCIATION; DRUG EFFECT; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY FIBROSIS; KIDNEY TUBULE DAMAGE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; TREATMENT DURATION; TREATMENT PLANNING;

ADULT; AGED; AGED, 80 AND OVER; CREATININE; CZECH REPUBLIC; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; GLOMERULONEPHRITIS, IGA; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROTEINURIA; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 84859319301     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr482     Document Type: Article

References (37)

1. Donadio JV, Bergstralh EJ, Grande JP et al. Proteinuria patterns and their association with subsequent end-stage renal disease in IgA nephropathy. Nephrol Dial Transplant 2002; 17: 1197-1203 (Pubitemid 34812063)
2. D́ Amico G. Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin Nephrol 2004; 24: 179-196
3. Ibels LS, Gyory AZ. IgA nephropathy:analysis of the natural history, important factors in the progression of renal disease, and a review of the literature. Medicine (Baltimore) 1994; 73: 79-102 (Pubitemid 24114627)
4. Novak J, Julian BA, Tomana M et al. IgA glycosylation and IgA immune complexes in the pathogenesis of IgA nephropathy. Semin Nephrol 2008; 28: 78-87
5. Mestecky J, Tomana M, Moldoveanu Z et al. Role of aberrant glycosylation of IgA1 molecules in the pathogenesis of IgA nephropathy. Kidney Blood Press Res 2008; 31: 29-37 (Pubitemid 351310031)
6. Gomes MM, Suzuki H, Brooks MT et al. Recognition of galactosedeficient O-glycans in the hinge region of IgA1 by N-acetylgalactosamine-specific snail lectins: a comparative binding study. Biochemistry 2010; 49: 5671-5682
7. Takahashi K, Wall SB, Suzuki H et al. Clustered O-glycans of IgA1: defining macro-and microheterogeneity by use of electron capture/transfer dissociation. Mol Cell Proteomics 2010; 9: 2545-2557
8. Johnson JR, John Feehally J. IgA nephropathy and Henoch-Schönlein Nephritis. Clin Nephrol 2003; 24: 319-329
9. Rychlik I, Jancova E, Tesar V et al. The Czech registry of renal biopsies. Occurrence of renal diseases in the years 1994-2000. Nephrol Dial Transplant 2004; 19: 3040-3049 (Pubitemid 40057626)
10. Coppo R, Cattran D, Roberts ISD et al. The new Oxford Clinico-Pathological Classification of IgA nephropathy. Prilozi 2010; 31: 241-248
11. Cattran D, Coppo R, Cook TH et al. The Oxford classification of IgA nephropathy: pathology definitions, correlations and reproducibility. Kidney Int 2009; 76: 534-545
12. Roberts ISD, Cook HT, Troyanov S et al. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and proposal for classification. Kidney Int 2009; 76: 546-556
13. Alamartine E, Sabatier JC, Berthoux FC. Comparison of pathological lesions on repeated renal biopsies in 73 patients with primary IgA glomerulonephritis: value of quantitative scoring and approach to final prognosis. Clin Nephrol 1990; 34: 45-51 (Pubitemid 20257883)
14. Katafuchi R, Kiyoshi Y, Oh Y et al. Glomerular score as a prognosticator in IgA nephropathy: its usefulness and limitation. Clin Nephrol 1998; 49: 1-8 (Pubitemid 28043359)
15. Lee SM, Rao VM, Franklin WA et al. IgA nephropathy: morphologic predictors of progressive renal disease. Hum Pathol 1982; 13: 314-322 (Pubitemid 12105183)
16. Haas M. Histologic subclassification of IgA nephropathy: a clinicopathologic study of 244 cases. Am J Kidney Dis 1997; 29: 829-842 (Pubitemid 27251835)
17. Wakai K, Kawamura T, Endoh M et al. A scoring system to predict renal outcome in IgA nephropathy: from a nationwide prospective study. Nephrol Dial Transplant 2006; 21: 2800-2808 (Pubitemid 44542234)
18. Manno C, Strippoli GF, D'Altri C et al. A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study. Am J Kidney Dis 2007; 49: 763-775 (Pubitemid 46802935)
19. Bartosik LP, Lajoie G, Sugar L et al. Predicting progression in IgA nephropathy. Am J Kidney Dis 2001; 38: 728-735
20. Feehally J, Barratt J, Coppo R et al. International IgA nephropathy network clinico-pathological classification of IgA nephropathy. Contrib Nephrol 2007; 157: 13-18
21. Walsh M, Sar A, Lee D et al. Histopathologic features aid in predicting risk for progression of IgA nephropathy. Clin J Am Soc Nephrol 2010; 5: 425-430
22. Brabcova I, Tesar V, Honsova E et al. Association of advanced vasculopathy and transforming growth factor-beta1 gene expression with immunoglobulinAnephropathy progression. Nephrol Dial Transplant 2011; 26: 573-579
23. Radford MG Jr, Donadio JV Jr, Bergstralh EJ et al. Predicting renal outcome in IgA nephropathy. J Am Soc Nephrol 1997; 8: 199-207 (Pubitemid 127455874)
24. Reich HN, Troyanov S, Scholey JW et al. Remission of proteinuria improves prognosis in IgA nephropathy. J Am Soc Nephrol 2007; 18: 3177-3183 (Pubitemid 350223978)
25. Hwang HS, Kim BS, Shin YS et al. Predictors for progression in immunoglobulin A nephropathy with significant proteinuria. Nephrology (Carlton) 2010; 15: 236-241
26. Coppo R, D'Amico G. Factors predicting progression of IgA nephropathies. J Nephrol 2005; 18: 503-512 (Pubitemid 41824469)
27. Pozzi C, Andrulli S, Pani A et al. Addition of azathioprine to corticosteroids does not benefit patients with IgA nephropathy. J Am Soc Nephrol 2010; 21: 1783-1790
28. Floege J, Eitner F. Combined immunosuppression in high-risk patients with IgA nephropathy? J Am Soc Nephrol 2010; 21: 1604-1606
29. Liu XW, Li DM, Xu GS et al. Comparison of the therapeutic effects of leflunomide and mycophenolate mofetil in the treatment of immunoglobulin A nephropathy manifesting with nephrotic syndrome. Int J Clin Pharmacol Ther 2010; 48: 509-513
30. Sugiura H, Takei T, ItabashiMet al. Effect of single-dose rituximab on primary glomerular diseases. Nephron Clin Pract 2010; 117: c98-c105
31. Piccoli A, Codognotto M, Tabbi MG et al. Influence of tonsillectomy on the progression of mesangioproliferative glomerulonephritis. Nephrol Dial Transplant 2010; 25: 2583-2589
32. FassettRG,Gobe GC,Peake JMet al.Omega-3 polyunsaturated fatty acids in the treatment of kidney disease. Am J Kidney Dis 2010; 56: 728-742
33. Firedman AN. Omega-3 fatty acid supplementation in advanced kidney disease. Semin Dial 2010; 23: 396-400
34. Uchiyama-Tanaka Y, Mori Y. Effects of eicosapentaenoic acid supplementation on immunoglobulin A nephropathy. Ther Apher Dial 2010; 14: 303-307
35. Krebs S, Omer B, Omer TN et al. Wormwood (Artemisia absinthium) for poorly responsive early-stage IgA nephropathy: a pilot uncontrolled trial. Am J Kidney Dis 2010; 56: 1095-1099
36. Chen YZ, Gao Q, Zhao XZ et al. Meta-analysis of Tripterygium wilfordii hook F in the immunosuppressive treatment of IgA nephropathy. Intern Med 2010; 49: 2049-2055
37. Ballardie FW, Roberts IS. Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy. J Am Soc Nephrol 2002; 13: 142-148 (Pubitemid 34042021)